CoViD-19 Patient in Reims University Hospital in March to April 2020

Medical context: Follow-up of a retrospective cohort of 499 cases of CoViD-19, hospitalized at the University Hospital of Reims during the health crisis, prospectively up to two years of follow-up.

Possible intervention for serological monitoring, leading to a change from category 3 to category 2 (French law on human person research)

Aim of the study: To know the factors of gravity of CoViD-19, to know its prognostic factors, to see how the evolution of the treatments implemented have influenced the fate of the patients.

Material and methods:

Type of study: cohort study Population: Patients in the CoViD-19 cohort - Reims Calendar: September 2020 - July 2022

Expected results: Better knowledge of the cares of patients with CoViD-19

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronavirus Infections Coronaviridae Infections Infections Nidovirales Infections RNA Virus Infections Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Reims

Reims, 51092, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient hospitalized for CoViD-19 infection during the health crisis, in a short-stay service of Reims University Hospital and included in Covid-19 Cohort
Age > 18 years
Patient who benefit from the national health insurance coverage
patient agree for participation (consent form signed)

Exclusion criteria

Patient protected by law

Treatment and study plan

Serology

Biological

biological blood samples withdrawn at 6, 12 and 24 months

Primary outcomes

Health status in the 2 years after CoViD-19 diagnosis

Time frame: 2 years follow up

status : dead or alive persistante respiratory distress (yes / no)

Sponsors and collaborators

Lead sponsor

CHU de Reims

Other

Registry information

Official study title

Follow-up CoViD-19 Patients Hospitalized in Reims University Hospital Between the 01/03/2020 and 30/04/2020

Acronym: COVID-Reims

Important dates

Study start: 2020
Primary completion: 2022
Study completion: 2022
First posted: Sep 17, 2020
Registry last updated: Aug 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed